Data is not available at this time.
Cofidur S.A. operates as a specialized electronic manufacturing services (EMS) provider in France, serving high-reliability industries such as aviation, defense, medical, and telecommunications. The company’s core revenue model is built on end-to-end solutions, including procurement, lean manufacturing, PCB re-engineering, and obsolescence management, catering to clients requiring precision and durability. By integrating design-to-cost strategies and co-development services, Cofidur differentiates itself in a competitive EMS landscape dominated by larger global players. Its focus on niche sectors like defense and medical equipment provides stability, as these industries demand stringent quality standards and long-term supplier relationships. The company’s lean manufacturing approach and refurbishing capabilities further enhance its value proposition, appealing to cost-conscious clients without compromising technical requirements. Despite its smaller scale, Cofidur’s regional expertise and tailored solutions allow it to maintain a defensible position in the French and European markets.
Cofidur reported revenue of €79.5 million in FY 2024, with net income of €1.6 million, reflecting a modest but stable profitability margin. Operating cash flow stood at €7.7 million, indicating efficient working capital management, while capital expenditures of €3.8 million suggest ongoing investments in production capabilities. The diluted EPS of €41.28 underscores earnings consistency relative to its market capitalization.
The company demonstrates steady earnings power, supported by its diversified industrial clientele and lean operational model. With an operating cash flow covering capital expenditures more than twice over, Cofidur maintains prudent reinvestment discipline. Its ability to generate cash from operations highlights capital efficiency, though its smaller scale limits absolute profitability compared to larger EMS peers.
Cofidur’s balance sheet shows €8.0 million in cash against €12.2 million in total debt, indicating manageable leverage. The net debt position of €4.2 million is modest relative to its equity base, suggesting financial stability. Liquidity appears adequate, with cash reserves covering near-term obligations, though the debt load warrants monitoring given the cyclical nature of its end markets.
Growth trends remain muted, reflecting the mature nature of its core markets, though niche demand in defense and medical sectors provides resilience. The company pays a dividend of €20 per share, signaling a commitment to shareholder returns, albeit with a high payout ratio that may limit reinvestment flexibility. Future growth likely hinges on operational efficiency gains rather than rapid top-line expansion.
With a market cap of €12.0 million, Cofidur trades at a low earnings multiple, reflecting its small-cap status and limited growth prospects. The low beta of 0.297 suggests relative insulation from broader market volatility, aligning with its stable but unspectacular performance. Investors likely view it as a steady, low-growth holding rather than a high-upside opportunity.
Cofidur’s strategic advantages lie in its specialized EMS expertise and entrenched relationships in regulated industries. The outlook remains stable, with demand driven by maintenance and refurbishment needs in its core sectors. However, scalability challenges and competition from larger EMS providers could constrain long-term upside unless the company diversifies into higher-growth verticals or expands geographically.
Company filings, Euronext Paris disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |